semaglutide affect birth control and Semaglutide: Safety Guide The impact of tirzepatide and

Wegovy is a prescription-only medicine containing semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist licensed for chronic weight management in adults with a BMI 30 kg/m (obesity) or 27 kg/m with weight-related comorbidities, as per NICE TA875

Both methods share complementary mechanisms that can enhance appetite suppression, improve glycemic control, and promote fat utilization

1 of 5 The injection imitates naturally occurring glucagon-like peptide one receptors (GLP-1) in your small intestine

Expert Rev Clin Pharmacol (2023) 16(2):16176

Were excited to help consumers access one of the most anticipated weight-loss treatments on the market, said Wendy Barnes, President and CEO of GoodRx